Zomedica Corp. (ZOM)
USD 0.1
(-0.21%)
USD 0.1
(-0.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -10.22 Million USD | 60.17% |
| 2023 | -25.66 Million USD | 86.74% |
| 2022 | -193.57 Million USD | -221.96% |
| 2021 | -60.12 Million USD | -11675.4% |
| 2020 | -510.58 Thousand USD | 73.68% |
| 2019 | -1.94 Million USD | 43.73% |
| 2018 | -3.44 Million USD | -7.09% |
| 2017 | -3.21 Million USD | 0.59% |
| 2016 | -3.23 Million USD | -2160.5% |
| 2015 | -143.28 Thousand USD | 30.91% |
| 2014 | -207.4 Thousand USD | -160.13% |
| 2013 | -79.73 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -10.22 Million USD | 60.17% |
| 2024 Q1 | -6.77 Million USD | 73.61% |
| 2024 Q3 | -20.03 Million USD | 24.49% |
| 2024 Q4 | -10.22 Million USD | 48.97% |
| 2024 Q2 | -26.52 Million USD | -291.8% |
| 2023 Q4 | -25.66 Million USD | 40.95% |
| 2023 Q1 | -191.06 Million USD | 1.3% |
| 2023 Q3 | -43.45 Million USD | 76.52% |
| 2023 FY | -25.66 Million USD | 86.74% |
| 2023 Q2 | -185.05 Million USD | 3.14% |
| 2022 Q1 | -274.78 Million USD | -357.04% |
| 2022 Q2 | -275.02 Million USD | -0.08% |
| 2022 Q3 | -269.93 Million USD | 1.85% |
| 2022 Q4 | -193.57 Million USD | 28.29% |
| 2022 FY | -193.57 Million USD | -221.96% |
| 2021 Q3 | -50.63 Million USD | -83.12% |
| 2021 Q2 | -27.65 Million USD | -385922.41% |
| 2021 Q4 | -60.12 Million USD | -18.74% |
| 2021 FY | -60.12 Million USD | -11675.4% |
| 2021 Q1 | 7167.00 USD | 101.4% |
| 2020 Q1 | -2.29 Million USD | -18.37% |
| 2020 Q4 | -510.58 Thousand USD | 79.48% |
| 2020 FY | -510.58 Thousand USD | 73.68% |
| 2020 Q2 | -5.82 Million USD | -153.5% |
| 2020 Q3 | -2.48 Million USD | 57.27% |
| 2019 Q4 | -1.94 Million USD | -268.3% |
| 2019 Q3 | -526.81 Thousand USD | 87.69% |
| 2019 Q1 | -3.13 Million USD | 9.08% |
| 2019 Q2 | -4.27 Million USD | -36.5% |
| 2019 FY | -1.94 Million USD | 43.73% |
| 2018 Q2 | -2.64 Million USD | -49.96% |
| 2018 Q4 | -3.44 Million USD | 24.44% |
| 2018 Q3 | -4.56 Million USD | -72.21% |
| 2018 FY | -3.44 Million USD | -7.09% |
| 2018 Q1 | -1.76 Million USD | 45.12% |
| 2017 Q1 | -82.12 Thousand USD | 22.98% |
| 2017 FY | -3.21 Million USD | 0.59% |
| 2017 Q4 | -3.21 Million USD | 16.52% |
| 2017 Q3 | -3.85 Million USD | -123.36% |
| 2017 Q2 | -1.72 Million USD | -2002.9% |
| 2016 Q1 | -142.99 Thousand USD | 17.18% |
| 2016 FY | -3.23 Million USD | -2160.5% |
| 2016 Q4 | -106.62 Thousand USD | 9.29% |
| 2016 Q3 | -117.53 Thousand USD | 10.59% |
| 2016 Q2 | -131.46 Thousand USD | 8.07% |
| 2015 FY | -143.28 Thousand USD | 30.91% |
| 2015 Q1 | -207.4 Thousand USD | 4.86% |
| 2015 Q4 | -172.65 Thousand USD | 9.87% |
| 2015 Q2 | -201.42 Thousand USD | 2.88% |
| 2015 Q3 | -191.56 Thousand USD | 4.9% |
| 2014 Q3 | -55.46 Thousand USD | 14.25% |
| 2014 FY | -207.4 Thousand USD | -160.13% |
| 2014 Q4 | -217.98 Thousand USD | -293.0% |
| 2014 Q2 | -64.68 Thousand USD | 0.0% |
| 2013 FY | -79.73 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| China Pharma Holdings, Inc. | 3.21 Million USD | 418.425% |
| cbdMD, Inc. | 1.88 Million USD | 642.279% |
| cbdMD, Inc. | 1.88 Million USD | 642.279% |